Simulation with cellsin vitroof tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes-Reference-Cited by-同舟云学术

Simulation with cellsin vitroof tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes

Published:2014-12 Issue:24 Volume:171 Page:5624-5635
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Maximov Philipp Y¹,McDaniel Russell E¹,Fernandes Daphne J¹,Korostyshevskiy Valeriy R¹,Bhatta Puspanjali¹,Mürdter Thomas E²,Flockhart David A³,Jordan V Craig¹

Affiliation:

1. Lombardi Comprehensive Cancer Center; Georgetown University; Washington, DC USA

2. Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology; Stuttgart Germany

3. Department of Medicine, Division of Clinical Pharmacology; Indiana University School of Medicine; Indianapolis Indiana USA

Funder

National Institutes of Health

U.S. Department of Defense

Susan G. Komen for the Cure

German Research Foundatrion

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12864/fullpdf

Reference40 articles.

1. The Concise Guide to PHARMACOLOGY 2013/14: Nuclear hormone receptors;Alexander;Br J Pharmacol,2013a

2. The Concise Guide to PHARMACOLOGY 2013/14: Enzymes;Alexander;Br J Pharmacol,2013b

3. Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships;Allen;Br J Pharmacol,1980

4. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Davies;Lancet,2011

5. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial;Davies;Lancet,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines;PLOS ONE;2024-02-26

2. A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects;Biomedicine & Pharmacotherapy;2024-02

3. Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer;npj Breast Cancer;2023-12-19

4. Tamoxifen Affects Aquaporin-3 Expression and Subcellular Localization in Rat and Human Renal Collecting Ducts;Cells;2023-04-12

5. Cross‐Ancestry Genome‐Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations;Clinical Pharmacology & Therapeutics;2023-01-31